Open AccessParainfluenza Virus Type 3 Infections in Hematopoetic Stem Cell Transplant Recipients: Response to Ribavirin Therapy
Author(s) -
Suparno Chakrabarti,
K.E. Collingham,
Kathleen Holder,
S. M. OYAIDE,
Deenan Pillay,
D Milligan
Publication year - 2000
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/317482
Subject(s) - ribavirin , medicine , stem cell , virus , virology , respiratory system , immunology , transplantation , hepatitis c virus , biology , genetics
Parainfluenza virus (PIV) infection can be a problem among hematopoetic stem cell transplant recipients. 125 patients were prospectively evaluated for respiratory viral infections. We describe 5 patients with PIV 3 infection and their response to early treatment with ribavirin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom